SKA3 Promotes Cell Growth in Breast Cancer by Inhibiting PLK-1 Protein Degradation

Technology in Cancer Research and Treatment - Tập 19 - Trang 153303382094748 - 2020
Liwei Ruan1, Pengpeng Li1, Langping Jin1
1Department of Breast and Thyroid, Shaoxing People's Hospital, Shaoxing, Zhejiang, China

Tóm tắt

Breast cancer (Bca) remains the most common form of malignancy affecting females in China, leading to significant reductions in the mental and physical health of those with this condition. While spindle and kinetochore associated complex subunit 3 (SKA3) is known to be linked with cervical cancer progression, whether it is similarly associated with Bca progression remains unknown. Using shRNA, we specifically knocked down the expression of SKA3 in Bca cell lines and then assessed the resultant changes in cell proliferation using CCK-8 and colony formation assays. In addition, we used western blotting to quantify the expression levels of relevant proteins in these cells, and we assessed the interaction between SKA3 and polo-like kinase-1 (PLK-1) via co-immunoprecipitation.In this study, we observed elevated SKA3 expression in Bca tissues and cell lines. When we knocked down SKA3 expression in Bca cells, we were able to determine that it functions in an oncogenic manner so as to promote the growth and proliferation of these cells in vitro. From a mechanistic perspective, we were able to show that in Bca cells SKA functions at least in part via interacting with PLK-1 and preventing its degradation. In summary, we found that SKA3 is able to regulate PLK-1 degradation in Bca cells, thus controlling their growth and proliferation. These results highlight SKA3 as a potentially viable target for anti-cancer drug development aimed at combatting Bca.

Từ khóa


Tài liệu tham khảo

10.1016/j.ccr.2009.03.022

10.1002/ijc.29210

10.3322/caac.21583

10.1186/bcr625

10.1016/j.molcel.2012.03.005

10.1091/mbc.e13-07-0421

10.1016/j.cub.2009.07.017

10.4161/cc.11.5.19384

10.1186/1471-2164-14-165

10.1186/s12935-018-0670-4

10.1007/s10585-015-9745-y

10.1007/s12672-019-00370-5

10.1016/j.suronc.2016.05.026

10.1002/mc.23083

10.1074/jbc.RA119.009881

10.1016/j.tranon.2016.10.003

10.1158/1535-7163.MCT-15-0897

10.1038/onc.2017.113

10.1007/s13304-017-0424-1

Bonilla JM, 2017, Radiologia, 59, 368, 10.1016/j.rx.2017.06.003

10.1016/j.soc.2019.08.004

10.3109/09540261.2013.852971

10.1016/j.cub.2005.05.026

10.1242/jcs.044321

10.1083/jcb.201203091

10.18632/oncotarget.16290

10.1155/2015/705745

10.1091/mbc.7.10.1639

Kim SA, 2010, Int J Oncol, 36, 867

10.1016/j.canlet.2014.08.029

Thông tin
Thông tin xuất bản

Technology in Cancer Research and Treatment

Tập 19

153303382094748

Thông tin tác giả